Circulating immune complexes in 50-year-old men as a strong and independent risk factor for myocardial infarction

Circulation

Volumn 102, Issue 21, 2000, Pages 2576-2581

  Mustafa, Awder ^a   Nityanand, Soniya ^a   Berglund, Lars ^b   Lithell, Hans ^b   Lefvert, Ann Kari ^a,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Antibodies; Antigens; Circulating immune complexes; Lipoproteins; Myocardial infarction

Indexed keywords

AUTOANTIBODY; CARDIOLIPIN; IMMUNOGLOBULIN G; LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ALLELE; ANTIGEN ANTIBODY COMPLEX; ARTICLE; ATHEROSCLEROSIS; CASE CONTROL STUDY; CONTROLLED STUDY; HEART INFARCTION; HOMOZYGOSITY; HUMAN; IMMUNE COMPLEX DISEASE; IMMUNIZATION; MAJOR CLINICAL STUDY; MALE; OXIDATION; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR;

EID: 0034700233     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.102.21.2576     Document Type: Article

References (50)

1. Biology of disease: Involvement of the immune system in human atherosclerosis: Current knowledge and unanswered questions
2. Antibodies to cardiolipin in young survivors of myocardial infarction: An association with recurrent cardiovascular events
3. Patients with early-onset peripheral vascular disease have increased levels of autoantibodies against oxidized LDL
4. Anti-cardiolipin antibodies and risk of myocardial infarction in a prospective cohort of middle-aged men
5. Autoantibody against oxidised LDL and progression of carotid atherosclerosis
6. Studies on antigen-antibody complexes, I: Elimination of soluble complexes from rabbit circulation
7. Immune complex mediated vasculitis increase coronary artery lipid accumulation in autoimmune-prone MRL mice
8. Soluble-complex formation after myocardial infarction
9. A survey for circulating immune complexes in patients with acute myocardial infarction: Use of a C1q-binding assay with soluble protein A as indicator
10. Circulating immune complexes in myocardial infarction
11. Studies on the occurrence of circulating immune complexes in vascular diseases
12. Immune complexes in myocardial infarction
13. Myocardial infarction due to coronary atherosclerosis in three young adults with systemic lupus erythematosus
14. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: Comparison with the Framingham study
15. Factors predicting a poor life prognosis in rheumatoid arthritis: An eight year prospective study
16. Association between circulating immune complexes, complement C4 null alleles, and myocardial infarction before age 45 years
17. Lipoprotein immune complexes and their role in atherosclerosis
18. Lipoprotein-antibody immune complexes: Their catabolism and role in foam cell formation
19. Low density lipoprotein metabolism by human macrophages activated with low density lipoprotein immune complexes: A possible mechanism of foam cell formation
20. Enhanced uptake and impaired intracellular metabolism of low density lipoprotein complexed with anti-low density lipoprotein antibodies
21. Enrichment of antibodies against phospholipids in circulating immune complexes (CIC) in the anti-phospholipid syndrome (APLS)
22. Antibodies to oxidized LDL and LDL-containing immune complexes as risk factors for coronary artery disease in diabetes mellitus
23. Autoantibodies against oxidized low density lipoproteins (oxLDL): Characterization of antibody isotype, subclass, affinity and effect on the macrophage uptake of oxLDL
24. The role of complement and its receptor in the elimination of immune complexes
25. Inherited deficiency of the fourth component of human complement
26. C4 null alleles and myocardial infarction
27. Association between circulating immune complexes and complement C4 null alleles in patients operated for atherosclerotic peripheral vascular disease before 50 years of age
28. Serum triglycerides are a risk factor for myocardial infarction but not for angina pectoris
29. The serum cholesterol ester fatty acid composition but not the serum concentration of alpha tocopherol predicts the development of myocardial infarction in 50-year-old men: 19 years follow-up
30. Protein measurement with the Folin phenol reagent
31. Density gradient centrifugation
32. C4 allotyping on plasma or serum: Application to routine laboratories
33. Inherited polymorphism of human C4 as revealed by desialyzation
34. Statement on the nomenclature of human C4 allotypes
35. Usefulness of densitometry in typing of human complement component C4
36. Antibodies against cardiolipin and oxidatively modified LDL in 50-year-old men predict myocardial infarction
37. Heterogeneity of autoantibodies against cardiolipin and oxidatively modified low density lipoproteins revealed by human monoclonal antibodies
38. Evaluation of the anti-cardiolipin antibody test: Report of an international workshop held 4 April 1986
39. Anti-cardiolipin antibodies and circulating immune complexes in type 1 diabetes mellitus: Increased prevalence and relation to vascular complications
40. Isolation and characterization of human antioxidized LDL autoantibodies
41. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man
42. Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits
43. Three types of naturally occurring modified lipoproteins induced intracellular lipid accumulation due to lipoprotein aggregation
44. Autoantibodies against low-density lipoprotein and atherogenic potential of blood
45. Cholesterol content of circulating immune complexes in patients with coronary stenosis and subjects without evidence of atherosclerosis
46. Characteristics of low density lipoprotein isolated from circulating immune complexes
47. Low-density lipoprotein modification occurring in human plasma possible mechanism of in vivo lipoprotein desialylation as a primary step of atherogenic modification
48. Circulating immune complexes containing chlamydial lipopolysaccharide in acute myocardial infarction
49. The disappearance kinetics and glomerular deposition of small-latticed soluble immune complexes